exenatide vs tirzepatide New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists Tirzepatide vs. Semaglutide for Weight

54 This trial emphasized that orforglipron might provide an alternative to injectable GLP-1 receptor agonists and oral semaglutide, with the prospect of less burdensome administration to achieve treatment goals in diabetics

This is especially important since recent research suggests that changes in gut bacteria may play a role in how effectively GLP-1 medications work for weight management

The actor died at his home in Manhattan on Monday, September 30, as a result of metastatic melanotic peripheral nerve sheath sarcoma, a rare type of cancer that he had been diagnosed with in July

CagriSema clinical trial results The REDEFINE 1 trial enrolled adults with obesity or overweight (BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity) without type 2 diabetes

Approved in April 2026, Foundayo is a versatile, once-daily oral medication allowing for scheduling flexibility without dietary limitations